Recent Media releases

• January 30, 2012

  • Sanofi Commits to Eliminate or Control Five Neglected Tropical Diseases

• January 24, 2012

  • Genzyme Announces FDA Approval of Framingham Manufacturing Plant

• January 18, 2012

  • Brazil Introduces Inactivated Polio Vaccine in National Immunization Program with Sanofi Pasteur Vaccine

• January 18, 2012

  • Genzyme Announces European Approval of Framingham Manufacturing Plant

• January 10, 2012

  • Sanofi and Venture Capital Firms, Third Rock Ventures and Greylock Partners, Jointly Launch Warp Drive Bio, a Biotechnology Company Combining Innovative Genomics Technologies for Natural Products Drug Discovery

• December 20, 2011

  • Genzyme Reports Top-line Results for TENERE Study of Oral Teriflunomide in Relapsing Multiple Sclerosis

• All media releases
• Sign up for e-mail alert
• RSS Media releases

Events

January 26, 2012

• Watch Christopher A. Viehbacher’ interview with CNBC

 

• All Corporate events
• All Press events

• Key facts & figures

Multimedia centre

• Sanofi Videos

 

• Image Library

 

Publications

• Annual Review 2010
• Annual Report on Form 20-F 2010
• CSR Reporting 2010
• Order our publications

 

Stock Market

• Feb 03, 2012 - 05.37 PM

  EURONEXT Paris (SAN) €55.95 +0.29%

• Feb 03, 2012 - 04.10 PM

  NYSE (SNY) $36.73 -0.20%